Analyst Coverage
| Firm | Analyst |
|---|---|
|
Baird
|
Brian Skorney
|
|
Bank of America Securities
|
Tazeen Ahmad
|
|
Barclays
|
Gena Wang
|
|
Bernstein
|
Will Pickering
|
|
BMO
|
Evan Seigerman
|
|
Canaccord Genuity
|
Whitney Ijem
|
|
Cantor Fitzgerald
|
Olivia Brayer
|
|
Citi
|
Geoff Meacham, Ph.D.
|
|
TD Cowen
|
Phil Nadeau, Ph.D.
|
|
Evercore ISI
|
Liisa Bayko
|
|
Goldman Sachs
|
Salveen Richter
|
|
Guggenheim Securities
|
Debjit Chattopadhyay
|
|
HC Wainwright
|
Andrew Fein
|
|
Jefferies
|
Michael Yee
|
|
J.P. Morgan
|
Jessica Fye
|
|
Maxim Group
|
Naz Rahman
|
|
Morgan Stanley
|
Terence Flynn
|
|
Needham & Company
|
Joseph Stringer
|
|
Oppenheimer
|
Jay Olson
|
|
Piper Sandler
|
Christopher Raymond
|
|
RBC
|
Brian Abrahams, M.D.
|
|
Redburn Atlantic
|
Steve Chesney
|
|
Scotiabank
|
Greg Harrison
|
|
Stifel
|
Paul Matteis
|
|
SVB Securities
|
David Risinger
|
|
Truist Securities
|
Joon Lee, M.D., Ph.D.
|
|
UBS Securities
|
Eliana Merle
|
|
Wells Fargo
|
Mohit Bansal
|
|
William Blair
|
Myles Minter, Ph.D.
|
|
Wolfe Research
|
Andy Chen
|
Vertex Pharmaceuticals is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Vertex Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vertex Pharmaceuticals or its management. Vertex Pharmaceuticals does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.